Position in LNTH
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,442
+$608 QoQ
Shares Held
13
+18.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#437
of 462 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $94,890 across 10 Drug Manufacturers - Specialty & Generic names. LNTH ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
663 | $47,643 | |
| 2 | VTRS |
Viatris Inc
|
1,074 | $17,055 | |
| 3 | HLN |
Haleon plc
|
992 | $9,255 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
290 | $7,136 | |
| 5 | PRGO |
PERRIGO Co plc
|
412 | $4,280 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
22 | $3,707 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
179 | $2,869 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
This page
|
13 | $1,442 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,442 | 13 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $834 | 11 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $399 | 6 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $81 | 1 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $195 | 2 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $178 | 2 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $329 | 3 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $160 | 2 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||